Skip to content

13F-HR filed by Ridgeback Capital Investments L.P.

Ridgeback Capital Investments L.P. filed this 13F-HR for the quarter ended 2013-12-31, filed 2014-05-15, with 5 holding rows worth $79,125,000.

Accession
0001140361-14-021566
Filed
2014-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2013

A holdings report, 5 entries on the cover page, a total value of $79,125,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $79,125,000 with VALUE read as thousands by filing date, 13F file number 028-12856. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SANGAMO THERAPEUTICS INC800677106COM2,900,000$40,281,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CELLDEX THERAPEUTICS INC NEW15117B103COM1,025,000$24,815,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
STEMLINE THERAPEUTICS INC85858C107COM506,699$9,931,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ARROWHEAD RESEARCH CORP042797209COM279,361$3,031,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
GERON CORP374163103COM225,000$1,067,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-14-021566this filing2014-05-15acceptance time not in the bulk data set